Vitrolife launch a new generation of Growth Factors and Cytokines for cultivation of stem cells


Vitrolife launch a new generation of Growth Factors and Cytokines for
cultivation of stem cells

The world's first biorisk-free growth factors and cytokines products.
Manufactured in barley grain, the products are xeno-free, serum-free,
endotoxin-free and present a new option for stem cell cultivation.

 

Through the signing of a Distribution and Supply Agreement, Vitrolife
secures worldwide rights to distribute, market and sell the Growth
factors and Cytokines produced in plants by ORF Genetics for cell
culture media. These new products are the world's first biorisk-free
growth factors and cytokines. Manufactured in barley grain, the products
are xeno-free, serum-free, endotoxin-free and present a new option for
stem cell cultivation.

“Patient safety is with us all the way - from development to the final
product, says Anna Mårtensson, Head of the Stem Cell business area at
Vitrolife. By using barley grain and bypassing the use of bacterial or
animal systems these products are contributing to a higher patient
safety and in addition, the stem cell therapy companies can enjoy an
easier regulatory clearance. These new growth factors and cytokines are
therefore fully in-line with our focus on providing researchers and cell
therapy companies high quality media, reagents and instruments that will
facilitate their use of stem cells for therapeutic purposes.”

October 1, 2010

Gothenburg

Magnus Nilsson

CEO

Queries should be addressed to:

Magnus Nilsson, CEO, phone +46 31 721 80 61

Anne-Lie Sveder, CFO, phone +46 31 721 80 13

Attachments

09302160.pdf